John Stafford Llc Marriage & Family Therapist Medicare: Not Enrolled in Medicare Practice Location: 45525 Highway 79 Unit 53, Aguanga, CA 92536 Phone: 760-459-4428 |
News Archive
Boehringer Ingelheim today announced overall survival (OS) results from the LUX-Lung 8 trial (NCT01523587) that directly compared the efficacy and safety of two EGFR-directed treatments, afatinib and erlotinib, in patients with advanced squamous cell carcinoma (SCC) of the lung, progressing after treatment with first-line chemotherapy. Treatment with afatinib significantly reduced the risk of death by 19%, extending the survival of patients to a median of 7.9 months compared to 6.8 months on erlotinib.
Behavioral Intervention Research in Hospice and Palliative Care: Building an Evidence Base sets forth research considerations and guidelines to build evidence-based interventions to improve end-of-life care.
CVS Caremark today announced results of a survey of the company's specialty pharmacy patients that provides insights into their views on medication adherence and their perceptions about the role of their specialty pharmacy. The survey results show nearly 70 percent of respondents believe their specialty pharmacy team played an important role in encouraging them to take their specialty medications as prescribed.
Despite deaths and hospitalizations linked to many new psychoactive substances (NPS), an international wastewater study led by the University of South Australia shows just how prevalent 'party pills' and 'bath salts' are in different parts of the world.
Abbott has announced that it has signed a new group purchasing agreement with Premier, Inc., a leading healthcare alliance, for a broad line of the company's diagnostic products.
› Verified 1 days ago